Latest Commercialisation News

Aurora Labs has reached a critical design freeze milestone under its Australian Defence Force contract, advancing its novel 3D-printed propulsion system towards testing and validation phases.

Sparc Technologies has launched a Share Purchase Plan offering eligible shareholders the chance to buy new shares at a 28.6% discount, aiming to raise up to $500,000 to fund key growth initiatives.

Carnegie Clean Energy has partnered with global industrial leader SKF to co-develop and manufacture the Power Take-Off system for its CETO wave energy technology, marking a key step in commercialising ocean energy in Europe.

Memphasys Limited has successfully trialed its RoXsta™ Mega Cell High-Throughput Assay, capable of processing 96 antioxidant tests in under an hour, promising a leap forward in rapid, cost-effective oxidative stress analysis.

Echo IQ has raised $17.3 million through a strongly supported institutional placement to fund US commercialization and FDA approval efforts for its EchoSolv AI cardiology products.

First Graphene has secured a multi-year exclusive deal to supply graphene-enhanced masterbatch for safety boots aimed at Southeast Asia’s mining sector, marking a significant step in commercialising advanced materials in industrial apparel.

Lunnon Metals has announced its inaugural Mineral Resource Estimate for the Lady Herial gold deposit, marking a rapid progression from discovery to resource in just 15 months. The shallow, high-grade deposit is poised for fast-tracked development amid strong gold prices.

Nanoveu Limited has expanded its capital raise to $2.7 million, led by a significant investment from CEO Mark Goranson and strong insider participation, to accelerate development across its semiconductor, 3D visualisation, and solar technology divisions.

A landmark High Court ruling in South Africa exempts upstream petroleum activities from the Gas Act, easing regulatory burdens for companies like Renergen and Tetra4.

Silex Systems reports steady progress on its TRL-6 uranium enrichment demonstration, targeting completion by end-2025, while securing initial US government funding to support commercialisation efforts.

Dimerix has received a US$30 million upfront payment from Amicus Therapeutics for exclusive US rights to DMX-200, a promising kidney disease therapy. The deal positions Dimerix for up to US$560 million in further milestones plus royalties, underpinning its global licensing strategy.

Altech Batteries has launched an operational pilot plant in Germany producing its proprietary Silumina Anodes, promising a 50% increase in lithium-ion battery capacity with improved longevity.